The European Medicines Agency (EMA) on Friday released a set of recommendations for providing Gilead’s investigational drug remdesivir under compassionate use programs to patients with coronavirus ...

Just before leaving The White House for Walter Reed National Military Medical Center, President Donald J. Trump tweeted an 18-second message, which also came after an experimental drug was ...

The European Medicines Agency (EMA) on Monday recommended expanding compassionate use programs for Gilead Sciences’ investigational drug remdesivir to treat coronavirus disease (COVID-19) patients who ...

The Food and Drug Administration’s expanded access program and state right-to-try laws seek to provide terminally ill patients with access to experimental drugs. Elizabeth Dzeng, MD, PhD, assistant ...

Among the whirlwind of news and medical information about President Trump since he was diagnosed with Covid-19, treated with experimental drugs, hospitalized, and released has been a lot of confusion ...